Atlas Trials

Evaluation of Treatment Response With CHOI and RECIST Criteria and CT Texture Analysis in Patients With Metastatic Colorectal Cancer Treated With Regorafenib

Clinical trial NCT02699073 · COMPLETED

Trial details

NCT number
NCT02699073
Sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2016-02-01
Primary completion
2017-12-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.